SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes.

Wannamethee, SG; Welsh, P; Papacosta, O; Ellins, EA; Halcox, JPJ; Whincup, PH; Sattar, N (2017) Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes. Atherosclerosis, 264. pp. 36-43. ISSN 1879-1484 https://doi.org/10.1016/j.atherosclerosis.2017.07.008
SGUL Authors: Whincup, Peter Hynes

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (909kB) | Preview

Abstract

BACKGROUND AND AIMS: The soluble receptor for advanced glycation end products (sRAGE) has been implicated in diabetic vascular complications. We have examined the association between sRAGE and cardiac markers [NT-proBNP and cardiac troponin T (cTnT)] and subclinical vascular markers in older men with and without diabetes. METHODS: We performed a cross-sectional study of 1159 men aged 71-92 years with no history of cardiovascular disease (myocardial infarction, stroke, heart failure, coronary artery bypass graft operation or angioplasty). Prevalent diabetes included men with a doctor diagnosis of diabetes, men with fasting glucose ≥7 mmol/l or HbA1c ≥ 6.5% (N = 180). Subclinical vascular measurements included carotid intima media thickness (cIMT), arterial stiffness [pulse wave velocity (PWV)], central aortic blood pressure and arterial wave reflections [central augmentation pressure (AP) and augmentation index (AIx)]. RESULTS: sRAGE was strongly and positively associated with renal dysfunction in men with and without diabetes. sRAGE was significantly and positively associated with NT-proBNP (but not cTnT) and AP and AIx in both groups of men after adjustment for CVD risk and metabolic risk markers, renal function and inflammation. However, no association was seen between sRAGE and central aortic blood pressure, cIMT or arterial stiffness as determined by PWV in either group. CONCLUSIONS: Higher plasma sRAGE was associated with increased NT-proBNP and markers of arterial wave reflections in men both with and without diabetes. Increased sRAGE may contribute to or be a marker of worsening cardiac dysfunction or HF. Further studies with cardiac imaging data are required to confirm this.

Item Type: Article
Additional Information: © 2017 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Arterial stiffness, Arterial wave reflections, Soluble receptor advanced glycation end products, Cardiovascular System & Hematology, 1103 Clinical Sciences, 1102 Cardiovascular Medicine And Haematology
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: Atherosclerosis
ISSN: 1879-1484
Language: eng
Dates:
DateEvent
September 2017Published
12 July 2017Published Online
11 July 2017Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
RG/13/16/30528British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PG/09/024British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PubMed ID: 28759844
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/109071
Publisher's version: https://doi.org/10.1016/j.atherosclerosis.2017.07.008

Actions (login required)

Edit Item Edit Item